Clinical Trials Logo

Clinical Trial Summary

The investigators wish to investigate neurobiological effects of serotonin 2A receptor modulation in healthy volunteers, contrasting effects of an agonist (psilocybin) and an antagonist (ketanserin). Magnetic resonance imaging (MRI) and positron emission tomography (PET) will be used as neuroimaging tools.


Clinical Trial Description

This project applies an experimental medicine strategy coupled with human functional and molecular neuroimaging to elucidate the effects of 5-HT2A receptor (5-HT2AR) modulation on brain function and mood in healthy individuals. We compare psilocybin (5-HT2AR agonist) and ketanserin (5-HT2AR antagonist) effects on brain function to identify neural mechanisms mediating the clinical effects of psilocybin and, more broadly, to establish this comparative strategy as a pathway for delineating pharmacological effects on the brain in humans. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03289949
Study type Interventional
Source Rigshospitalet, Denmark
Contact Gitte M Knudsen, Professor
Phone +45 35456720
Email gmk@nru.dk
Status Recruiting
Phase Phase 1
Start date March 3, 2017
Completion date June 1, 2027

See also
  Status Clinical Trial Phase
Completed NCT01860287 - The Effects of Buprenorphine on Responses to Verbal Tasks Early Phase 1
Recruiting NCT05079516 - Neural Basis of Sensory Learning: Brain Regions N/A
Recruiting NCT05953038 - LSD Occupancy of the Serotonin 2A Receptor in the Human Brain Early Phase 1
Completed NCT03541473 - Phosphate Metabolites in Brain of Humans Aged 50+ N/A
Recruiting NCT05739994 - Frontal and Parietal Contributions to Proprioception and Motor Skill Learning N/A
Completed NCT04443647 - Influence of Oxytocin on Approach-avoidance Tendencies to Social and Non-social Stimuli N/A
Recruiting NCT05374460 - Factors Affecting Sensory and Motor Learning N/A
Recruiting NCT05124301 - Neural Basis of Sensory and Motor Learning: Functional Connections N/A